-
Orgenesis to Acquire Tamir Bio Assets
contractpharma
April 15, 2020
Aims to combine ranpirnase antiviral platform with Bioxome technology for enhanced payload delivery directly to cells.
-
Servier Acquires Cancer Biotech Symphogen
contractpharma
April 08, 2020
Strengthens R&D pipeline by acquiring antibody pipeline and next-gen antibody technologies.
-
Servier agrees to acquire Symphogen
pharmaceutical-technology
April 07, 2020
French pharmaceutical company Servier has signed a definitive agreement to acquire 100% shares in Danish therapeutic antibody discovery firm Symphogen.
-
Frontage Laboratories Acquires Biotranix
contractpharma
April 06, 2020
Frontage Holdings Corporation, a contract research organization (CRO) providing integrated, science-driven research, analytical and development services with presence in both North America and China.
-
DSM completes acquisition of Human Milk Oligosaccharides supplier, Glycom
expresspharma
April 06, 2020
There is significant interest in HMO use as a dietary supplement and potentially in food and beverage and pet food applications, and in fulfilling unmet medical nutrition needs, such as irritable bowel syndrome.
-
Aurobindo, Sandoz call off $900 million deal
expresspharma
April 03, 2020
In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc.
-
Aphena Acquires Konsyl Pharma Facility in Easton, MD
contractpharma
March 24, 2020
Renovations and the installation of new equipment are underway, with plans to add an additional 100 jobs.
-
AbbVie, Allergan megamerger set for May close
pharmatimes
March 23, 2020
AbbVie has released an update on its pending acquisition of Allergan, announcing that the companies have entered into a consent decree agreement with staff of the US Federal Trade Commission (FTC) regarding the deal.
-
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
prnasia
March 20, 2020
The businesses to be acquired are part of Danaher's Life Sciences platform and include various laboratory and bioprocessing technologies that are complementary to the portfolios of both Sartorius divisions.
-
AcelRx to Acquire Tetraphase
americanpharmaceuticalreview
March 19, 2020
AcelRx Pharmaceuticals announced a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock for stock deal at an exchange ratio of 0.6303 shares of AcelRx ...